The following is a news release from the Idaho Attorney General's Office: BOISE, Idaho — On February 2, 2026, Attorney General Labrador joined a coalition of 48 states and territories announcing ...

Last year, the U.S. Senate Special Committee on Aging launched a bipartisan effort to expose the public health and national security risks America’s overreliance on foreign-made generic drugs poses to ...

— Adrian García, CEO of Saya Bio. MEXICO CITY, MEXICO, January 26, 2026 /EINPresswire.com/ — Saya Biologics (Saya Bio), a Mexican biopharmaceutical company ...

Oklahomans who purchased certain generic prescription drugs between 2009 and 2019 may be eligible for compensation after two pharmaceutical companies agreed to pay $17.85 million to settle allegations ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Senators introduced legislation on Thursday that would ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Emory is the data editor at ...

New Jersey has joined 42 other states in suing global pharmaceutical company Novartis and its spin-off Sandoz for engaging in what they describe as “one of the most egregious examples of ...

Novartis NOVN-1.46%decrease; red down pointing triangle said it expected a key profitability metric to decline this year in large part due to increased competition in the U.S. from generic drug ...

NASHVILLE, Tenn. — The Tennessee Attorney General's Office announced that states across the country reached new settlements totaling $17.85 million with two drug companies over alleged generic ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company plans to use an ...

This weight-loss leader was drubbed last year. It's a popular pick as a 2026 rebound candidate. More than that popularity, it has credible catalysts to bounce back this year. Fast-forward to 2026, and ...